Literature DB >> 1471244

Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.

P H Pinkerton1, A S Coovadia, J Goldstein.   

Abstract

In view of the continuing controversy regarding the use of immediate-spin crossmatch procedures in preparing blood for transfusion to patients in whom unexpected clinically significant antibodies have not been found by antibody screening by the indirect antiglobulin test (IAT), a review of 8 years' experience with such a policy was conducted. In that period, 54,725 units of packed red cells or whole blood were transfused to 10,146 patients. Four clinically overt delayed hemolytic transfusion reactions and 18 clinically silent delayed serologic transfusion reactions were found. In 3 of the 22 patients, the offending antibody(ies) were detectable in the pretransfusion serum by an enzyme IAT, but none was detectable by routine saline IAT against either a three-cell screening panel or the transfused cells. Thus, the incorporation of saline indirect antiglobulin crossmatch would not have prevented the delayed reactions. It can be concluded that the use of a saline indirect antiglobulin crossmatch offers no significant advantage over the current policy of using only immediate-spin crossmatch for those patients whose pretransfusion serum gives negative results in a three-cell screen using a saline IAT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471244     DOI: 10.1046/j.1537-2995.1992.32993110751.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

Review 1.  Is it time to give up the crossmatch?

Authors:  J P Wallis
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 2.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

3.  Transfusion management using a remote-controlled, automated blood storage.

Authors:  Pasqualepaolo Pagliaro; Rosalia Turdo
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

4.  First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.

Authors:  Aseem Kumar Tiwari; Geet Aggarwal; Ravi C Dara; Dinesh Arora; Gautam Kumar Gupta; Vimarsh Raina
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun

5.  Advantages of type and screen policy: Perspective from a developing country!

Authors:  Geet Aggarwal; Aseem K Tiwari; Dinesh Arora; Ravi C Dara; Devi P Acharya; Gunjan Bhardwaj; Jyoti Sharma
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun

6.  The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Ryad Tamouza; Gama P Le Bouder; Ramita Dewan; Naomi L C Luban; Jacqueline Lasserre; Jacqueline Maury; François Lionnet; Rajagopal Krishnamoorthy; Robert Girot; Stanislav Vukmanovic
Journal:  Clin Dev Immunol       Date:  2013-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.